MIDDLE EAR EFFUSION LEVELS OF CEFPODOXIME AFTER ORAL SUSPENSION ADMINISTRATION

口服混悬液给药后头孢泊肟的中耳积液水平

• 批准号: 6246334
• 负责人: DAVID Peter MCCORMICK
• 金额: $ 2.71万
• 依托单位: UNIVERSITY OF TEXAS MED BR GALVESTON
• 依托单位国家: 美国
• 财政年份: 1997
• 资助国家: 美国
• 起止时间: 1997-01-06 至 1997-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6246334
• 关键词: antibacterial agents; bacterial disease; child (0-11); clinical research; clinical trials; drug screening /evaluation; ear disorder chemotherapy; exudate /transudate; human subject; human therapy evaluation; microorganism disease chemotherapy; oral administration; otitis media; pediatric pharmacology; pharmacokinetics

The purpose of this study is to determine the penetration of cefpodoxime into middle ear effusion of pediatric patients with acute otitis media following administration of Vantin Oral Suspension as 5 mg/kg (200 mg maximum) twice daily.

本研究的目的是测定头孢泊肟的渗透性 小儿急性中耳炎中耳积液的治疗 在给予5 mg/kg（200 mg）的Vantin口服混悬液后 最多）每日两次。